Tiny dose, big data: healthy volunteers help map RE104's journey through the body
NCT ID NCT07146191
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a single tiny dose of RE104 moves through and leaves the body in 8 healthy adults. Researchers measured the drug and its breakdown products in blood, urine, and stool over at least a week. The goal was purely to understand absorption and elimination, not to treat any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANT STUDY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PPD Inc.
Austin, Texas, 78744, United States